Genome-wide association study of statin-induced myopathy in patients recruited using the UK clinical practice research datalink

Autor: Eunice Zhang, Joshua C. Bis, Maryse Lapeyre-Mestre, Jennifer A. Brody, Tjeerd van Staa, Bruce M. Psaty, Hector Chinoy, Ana Alfirevic, Andrea L. Jorgensen, Munir Pirmohamed, Susan R. Heckbert, Ben Francis, James S. Floyd, Anita Conforti, Mariam Molokhia, Daniel F. Carr
Jazyk: angličtina
Rok vydání: 2019
Předmět:
medicine.medical_specialty
Statin
Databases
Factual

Pharmacogenomic Variants
medicine.drug_class
Genome-wide association study
Single-nucleotide polymorphism
Polymorphism
Single Nucleotide

Severity of Illness Index
030226 pharmacology & pharmacy
Article
03 medical and health sciences
0302 clinical medicine
Muscular Diseases
Risk Factors
Internal medicine
medicine
Adverse Drug Reaction Reporting Systems
Humans
SNP
Genetic Predisposition to Disease
Pharmacology (medical)
adverse dug reaction
genome wide association study
myopathy
statin
Myopathy
Exome
Pharmacology
biology
Liver-Specific Organic Anion Transporter 1
business.industry
Research
Reproducibility of Results
Articles
Odds ratio
United Kingdom
3. Good health
Case-Control Studies
030220 oncology & carcinogenesis
biology.protein
Hydroxymethylglutaryl-CoA Reductase Inhibitors
medicine.symptom
SLCO1B1
business
Genome-Wide Association Study
Zdroj: Clinical Pharmacology and Therapeutics
Clinical pharmacology and therapeutics
Carr, D F, Francis, B, Jorgensen, A L, Zhang, E, Chinoy, H, Heckbert, S R, Bis, J C, Brody, J A, Floyd, J S, Psaty, B M, Molokhia, M, Lapeyre-Mestre, M, Conforti, A, Alfirevic, A, van Staa, T & Pirmohamed, M 2019, ' Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink ', Clinical Pharmacology & Therapeutics . https://doi.org/10.1002/cpt.1557
Carr, D F, Francis, B, Jorgensen, A L, Zhang, E, Chinoy, H, Heckbert, S R, Bis, J C, Brody, J A, Floyd, J S, Psaty, B M, Molokhia, M, Lapeyre-Mestre, M, Conforti, A, Alfirevic, A, van Staa, T & Pirmohamed, M 2019, ' Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink ', Clinical Pharmacology and Therapeutics . https://doi.org/10.1002/cpt.1557
DOI: 10.1002/cpt.1557
Popis: Statins can be associated with myopathy. We have undertaken a genomewide association study (GWAS) to discover and validate genetic risk factors for statin-induced myopathy in a “real-world” setting. One hundred thirty-five patients with statin myopathy recruited via the UK Clinical Practice Research Datalink were genotyped using the Illumina OmniExpress Exome version 1.0 Bead Chip and compared with the Wellcome Trust Case-Control Consortium (n = 2,501). Nominally statistically significant single nucleotide polymorphism (SNP) signals in the GWAS (P −5) were further evaluated in several independent cohorts (comprising 332 cases and 449 drug-tolerant controls). Only one (rs4149056/c.521C>T in the SLCO1B1 gene) SNP was genomewide significant in the severe myopathy (creatine kinase > 10 × upper limit of normal or rhabdomyolysis) group (P = 2.55 × 10−9; odds ratio 5.15; 95% confidence interval 3.13–8.45). The association with SLCO1B1 was present for several statins and replicated in the independent validation cohorts. The data highlight the role of SLCO1B1 c.521C>T SNP as a replicable genetic risk factor for statin myopathy. No other novel genetic risk factors with a similar effect size were identified.
Databáze: OpenAIRE